# PCORI Program Details

## CER 2026 Funding Announcements - Comprehensive Requirements

---

## Active and Upcoming Funding Opportunities

### Current Status (as of February 2026)

| Status | Programs |
|--------|----------|
| **Open for LOIs** | Cycle 1 2026 research PFAs (LOI deadline: January 6, 2026 - PASSED) |
| **LOIs Under Review** | Broad Pragmatic Studies, PLACER, Methods, Implementation (Cycle 1 2026) |
| **Applications Open** | Full applications due May 5, 2026 (if invited) |
| **Opening April 1, 2026** | Cycle 2 2026 research PFAs |
| **Engagement Awards Open** | Capacity Building, Dissemination, Convening Support |

---

## Broad Pragmatic Studies (BPS) - Cycle 1 2026

### Program Overview

PCORI invites applications for high-impact patient-centered comparative clinical effectiveness research (CER) projects. The program supports:
- Individual or cluster randomized controlled trials
- Natural experiments
- Observational studies
- Focus on clinically meaningful outcomes important to patients

### Award Categories

| Category | Direct Costs | Requirements |
|----------|--------------|--------------|
| **Category 1** | Up to $5 million | Standard pragmatic research |
| **Category 2** | $5 - $12 million | Requires justification for larger scope and resources |
| **Category 3** | Up to $12 million | Must use PCORnet; requires 2+ Clinical Research Networks |

**Total Available Funding:** $120 million
**Project Duration:** Up to 5 years (all categories)

### Key Dates - Cycle 1 2026

| Milestone | Date |
|-----------|------|
| Application System Opens | December 2, 2025 |
| Applicant Town Hall | December 8, 2025 |
| **LOI Deadline** | January 6, 2026, 5 pm ET |
| LOI Status Notification | February 3, 2026 |
| **Full Application Deadline** | May 5, 2026, 5 pm ET |
| Merit Review | July 2026 |
| Awards Announced | December 2026 |
| Earliest Start Date | April 2027 |

### Research Design Requirements

**Eligible Studies Must Include:**
- Adequate sample sizes for precise effect estimation
- Heterogeneity of treatment effect analysis capability
- Well-justified and validated outcomes that are:
  - Clinically meaningful
  - Considered important by patients
- Consideration of hybrid effectiveness-implementation approaches

**Ineligible Studies:**
- Studies focused solely on method development
- Dissemination-only projects without effectiveness components
- Strict implementation studies (without comparative effectiveness)

### Special Areas of Emphasis (SAEs)

#### 1. Obesity Treatment & Management
- Compare lifestyle interventions, anti-obesity medications, endoscopic procedures, bariatric surgery, and combinations
- Objective, clinically meaningful primary outcomes preferred
- Patient-reported outcomes as secondary measures

#### 2. Menopausal Symptoms
- Hormonal and non-hormonal pharmacologic interventions
- Non-pharmacologic treatments
- Health-system or community-level interventions
- **Special Interest Populations:**
  - Early menopause
  - Surgically-induced menopause
  - Breast cancer survivors

#### 3. Care Delivery for Intellectual and Developmental Disabilities (IDD)
- Systems-level strategies improving access, quality, and care navigation
- **Key Outcomes:**
  - Quality of life
  - Community participation
  - Healthcare utilization

### PCORnet Category 3 Requirements

Studies must:
- Utilize PCORnet's clinical research infrastructure
- Include two or more Clinical Research Networks
- Conduct national-scale observational studies or pragmatic trials
- Leverage the PCORnet Common Data Model
- Share study progress, performance metrics, and best practices with the network

---

## Phased Large Awards for Comparative Effectiveness Research (PLACER) - Cycle 1 2026

### Program Overview

PLACER supports high-impact patient-centered CER projects addressing critical healthcare decisions where evidence is insufficient. Projects require:
- Individual-level or cluster randomized controlled trials
- Significant scale comparing interventions already in current use
- Established efficacy of interventions being compared

### Award Structure

| Phase | Maximum Funding | Duration | Purpose |
|-------|-----------------|----------|---------|
| **Feasibility** | $2 million | 18 months | Infrastructure, engagement, operational testing |
| **Full-Scale** | $20 million | 5 years | Complete study implementation |
| **Total** | $22 million | ~6.5 years | Complete project |

**Total Available Funding:** $120 million
**Minimum Expected Budget:** >$12 million in direct costs

### Feasibility Phase Requirements

The feasibility phase supports:
- Study refinement
- Infrastructure establishment
- Patient and stakeholder engagement
- Testing of study operations
- Recruitment, enrollment, and randomization testing

**Prohibited Activities:**
- Establishing intervention efficacy or effect size during feasibility phase

### Full-Scale Phase Transition

Approval to proceed is contingent on achieving:
- Specific milestones defined in the proposal
- Deliverables from the feasibility phase
- Demonstrated recruitment and enrollment capability

### Data Coordinating Center Requirement

PCORI mandates shared trial leadership with a Data Coordinating Center (DCC) to provide:
- Independent role in study leadership
- Advice on analytical aspects
- Statistical oversight
- Data management for both study phases

### Key Dates - Cycle 1 2026

| Milestone | Date |
|-----------|------|
| **LOI Deadline** | January 6, 2026, 5 pm ET |
| LOI Status Notification | February 3, 2026 |
| **Full Application Deadline** | May 5, 2026, 5 pm ET |
| Merit Review | July 2026 |
| Awards Announced | December 2026 |
| Earliest Start Date | April 2027 |

---

## Methods Research PFA - Cycle 1 2026

### Program Overview

PCORI seeks studies addressing high-impact methodological gaps in patient-centered CER.

### Award Parameters

| Parameter | Value |
|-----------|-------|
| **Maximum Direct Costs** | $750,000 |
| **Maximum Duration** | 3 years |
| **Total Available** | $12 million |
| **Earliest Start** | April 2027 |

### Key Dates - Cycle 1 2026

| Milestone | Date |
|-----------|------|
| PFA Opens | December 2, 2025, 9 am ET |
| Applicant Webinar | December 4, 2025, 12-1 pm ET |
| **LOI Deadline** | January 6, 2026, 5 pm ET |
| LOI Status Notification | February 3, 2026 |
| **Full Application Deadline** | May 5, 2026, 5 pm ET |
| Merit Review | July 2026 |
| Awards Announced | December 2026 |

### Priority Topic Areas (2026)

#### 1. Methods to Improve AI/ML Use in CER
- Applications of AI/ML to augment or transform research methodologies
- AI/ML approaches to enhance health communication
- Development and validation of AI/ML methods for CER
- **Added for Cycle 2 2026:** Expanded AI/ML application topics

#### 2. Methods to Improve Study Design
- Innovative trial designs
- Adaptive designs
- Platform trials

#### 3. Methods to Support Data Research Networks
- PCORnet methods
- Data quality
- Interoperability

#### 4. Methods Related to Ethical and Human Subjects Protections
- Informed consent innovations
- Privacy-preserving methods
- Participant protection approaches

---

## Retrospective Observational Studies PFA - Cycle 1 2026

### Program Overview

Leverage existing, ready-to-analyze data sources for new CER studies.

### Award Parameters

| Parameter | Value |
|-----------|-------|
| **Maximum Direct Costs** | $2 million |
| **Maximum Duration** | 18 months |
| **Data Requirement** | Evidence of data access at application |

### Focus Areas

- Cancer
- Pain
- Substance Use
- Maternal Morbidity and Mortality
- Intellectual and Developmental Disabilities
- Sensory Health
- Metabolic and Endocrine Health
- Mental and Behavioral Health
- Rare Diseases

### Requirements

- Must leverage existing, ready-to-analyze data sources
- Not for development or validation of new data networks
- Data access evidence required at application

---

## Engagement Awards - Spring 2026 Cycle

### Capacity Building Award

| Parameter | Value |
|-----------|-------|
| **Maximum Total Costs** | $300,000 |
| **Maximum Duration** | 2 years |
| **Program Total (FY2026)** | $25 million across all engagement awards |
| **Earliest Start** | January 1, 2027 |

### Key Dates - Spring 2026 Cycle

| Milestone | Date |
|-----------|------|
| Portal Opens | January 21, 2026, 9 am ET |
| **LOI Deadline** | March 30, 2026, 5 pm ET |
| LOI Status Notification | Within 60 calendar days |
| **Full Proposal Deadline** | July 13, 2026, 5 pm ET |

### Eligibility Requirements

Projects must demonstrate:
- Understanding of patient-centered CER basics
- Need for additional capacity building among target groups
- Pathway to future patient-centered CER participation
- Plan to generate and share learnings
- Organizational experience engaging target communities
- Patient/caregiver leadership throughout project

### Target Populations

- Patients and family members/caregivers
- Community organizations
- Healthcare providers not typically engaged in research
- Advocacy organizations
- Health systems leadership

---

## Cycle 2 2026 Funding Opportunities (Opening April 1, 2026)

### Programs Available

| Program | LOI Deadline | Application Deadline |
|---------|--------------|---------------------|
| Addressing Sensory Health Needs Across the Lifespan | April 28, 2026 | September 1, 2026 |
| Broad Pragmatic Studies | April 28, 2026 | September 1, 2026 |
| PLACER | April 28, 2026 | September 1, 2026 |
| Advancing the Science of Engagement | April 28, 2026 | September 1, 2026 |
| Methods PFA | April 28, 2026 | September 1, 2026 |
| HSII Implementation Projects | April 28, 2026 | September 1, 2026 |

---

## Patient Engagement Requirements (All Programs)

### Foundational Expectations for Partnerships in Research

All research applicants must address PCORI's six Foundational Expectations:

| # | Expectation | Description |
|---|-------------|-------------|
| 1 | **Representative Involvement** | Partners reflecting affected patients and communities |
| 2 | **Early & Ongoing Engagement** | Partners contribute throughout all study phases |
| 3 | **Dedicated Funds & Compensation** | Budget for engagement and partner payment |
| 4 | **Build Capacity as Team** | Training, support, and skill development |
| 5 | **Meaningful Decision-Making** | Partners included in governance and decisions |
| 6 | **Ongoing Assessment** | Evaluate and improve engagement approaches |

### Implementation Requirements

1. **At Application:**
   - Provide overview of engagement approach
   - Demonstrate how Foundational Expectations are addressed
   - Use multiple approaches along engagement continuum
   - Include budget for engagement activities and compensation

2. **During Project (Months 12-18):**
   - Required assessment of engagement activities
   - Documentation of engagement effectiveness
   - Plan for adjustments based on assessment

### Non-Compliance Consequences

Studies proposing only input approaches (surveys, focus groups alone) will be:
- Deemed nonresponsive
- Not considered for funding

---

## LOI Requirements

### General LOI Process

1. **Submission:** Through PCORI Online before full application invitation
2. **Review:** Two-step process
   - Administrative review for compliance
   - Programmatic review for alignment
3. **Timeline:** LOI status notification typically within 30 days
4. **Invitation:** Only invited applicants may submit full applications

### LOI Components (Research Awards)

| Component | Description |
|-----------|-------------|
| Research Question | Clear, patient-centered question |
| Background | Current evidence and gaps |
| Study Population | Target patients and settings |
| Comparators | Interventions being compared |
| Outcomes | Patient-centered outcome measures |
| Study Design | Methodological approach |
| Sample Size/Power | Adequacy justification |
| Engagement Strategy | Patient/stakeholder involvement plan |
| PI/Team Qualifications | Experience and expertise |
| Duration and Costs | Project scope |
| References | Supporting literature |

### LOI Template Requirements

- Download PFA-specific LOI template from funding announcement
- Templates differ between PFAs and cycles
- Use current cycle template only
- Adhere to page limits (excluding references)

### Multiple Submissions

Allowed under these conditions:
- No significant scientific overlap between LOIs
- PI may serve in different roles on multiple LOIs
- Overlapping or duplicate submissions will be disqualified

### Resubmission Policy (Effective Cycle 3 2025)

- Previously declined LOIs may be resubmitted to any open research PFA
- Must be responsive to the new PFA
- Must address major weaknesses from prior review

---

## Full Application Requirements

### Required Templates

| Template | Purpose |
|----------|---------|
| Research Plan | Study design and methodology |
| Letters of Support Table | Partner commitments |
| Milestones Template | Key deliverables and timeline |
| Methodology Standards Checklist | PCORI standards adherence |
| Budget Justification | Cost documentation |
| Subcontractor Budget (if applicable) | Sub-award details |
| Leadership Plan (if dual-PI) | Role delineation |
| Scientific PI & Key Personnel | Team documentation |
| Patient/Stakeholder Partner Template | Engagement team |
| Project/Performance Sites | Research locations |
| Resubmission Letter (if applicable) | Response to prior review |

### Additional PLACER Templates

| Template | Purpose |
|----------|---------|
| PLACER LOI Template | Specific to phased award |
| PLACER Research Plan Template | Phase-specific planning |
| PLACER Milestones Template | Feasibility and full-scale milestones |
| PCORI 10-Year Budget Template | Long-term budget planning |

---

## Merit Review Criteria

### Scoring System

- **Scale:** 1-9 points
- **1-3:** Minor weaknesses (fundable range)
- **4-6:** Moderate weaknesses
- **7-9:** Major weaknesses (not fundable)

### Review Panel Composition

- Scientific reviewers
- Patient representatives
- Other stakeholder representatives
- All scores weighted equally

### Key Evaluation Criteria

Applications evaluated on six criteria focusing on:

1. **Scientific Rigor**
   - Study design appropriateness
   - Analytical approach
   - Methodology standards adherence

2. **Patient-Centeredness**
   - Outcomes important to patients
   - Stakeholder involvement in design

3. **Engagement Quality**
   - Foundational Expectations adherence
   - Meaningful partnership demonstration

4. **Feasibility**
   - Team qualifications
   - Resources and infrastructure
   - Recruitment plans

5. **Potential Impact**
   - Gap in current evidence
   - Applicability to decision-making
   - Population affected

6. **Innovation**
   - Novel approaches
   - Advancement of field

---

## Coverage of Patient Care Costs

### Policy

- Applicants may request coverage of patient care costs
- Subject to PCORI criteria
- Funding not guaranteed
- Requests exceeding 15% of total research budget require strong justification

### Eligible Costs

- Study-related clinical procedures
- Laboratory tests required by protocol
- Imaging studies
- Participant incentives and compensation

---

## Mentorship Support

### Eligible for Funding

- Early/mid-career investigators
- Researchers transitioning to patient-centered CER
- Patient/community partners

### Requirements

- Must meet PCORI-specified criteria
- Structured mentorship plan required
- Budget allocation for mentorship activities

---

## Application Deferral Policy

### Standard Policy

- Invited applicants may defer once to next PFA cycle
- May cross calendar years
- Must remain responsive to original PFA requirements

---

## Contact Information

### General PFA Inquiries
- **Email:** pfa@pcori.org
- **Website:** https://www.pcori.org/funding-opportunities

### Applicant Resources
- **Town Halls:** Virtual sessions for each PFA cycle
- **FAQs:** Available on PCORI website
- **Templates:** Downloadable from funding announcements

---

*Document compiled: February 2, 2026*
*Sources: PCORI Funding Announcements, FAQs, and Applicant Resources*
